F38H4.16

Caenorhabditis elegans

Is affected by lin-14 and lin-4 based on microarray studies.

T12B5.18

Caenorhabditis elegans

Is affected by sir-2.1; lin-14; and lin-4 based on microarray studies.

suv-2

Caenorhabditis elegans

F39E9.25

Caenorhabditis elegans

Enriched in intestine based on microarray studies. Is affected by lin-14 and lin-4 based on microarray studies.

F39E9.19

Caenorhabditis elegans

Enriched in intestine based on microarray studies. Is affected by lin-14 and lin-4 based on microarray studies.

Y51A2A.18

Caenorhabditis elegans

Is affected by lin-14 and lin-4 based on microarray studies. Is affected by Atrazine based on microarray studies.

str-58

Caenorhabditis elegans

Enriched in anchor cell based on RNA-seq studies. Is affected by lin-14 and lin-4 based on microarray studies.

lin-48

Caenorhabditis elegans

Predicted to enable DNA-binding transcription factor activity, RNA polymerase II-specific and RNA polymerase II cis-regulatory region sequence-specific DNA binding activity. Involved in anatomical structure morphogenesis and response to salt stress. Located in nucleus. Expressed in ciliated neurons; interfacial epithelial cell; intestine; labial sensillum; and tail. Human ortholog(s) of this gene implicated in posterior polymorphous corneal dystrophy 1. Is an ortholog of human OVOL1 (ovo like transcriptional repressor 1) and OVOL2 (ovo like zinc finger 2).

C33A12.16

Caenorhabditis elegans

Is affected by clk-1; lin-14; and lin-4 based on microarray studies. Is affected by resveratrol and Sirolimus based on microarray studies.

F39E9.20

Caenorhabditis elegans

Enriched in intestine based on microarray studies. Is affected by glp-1; lin-14; and lin-4 based on RNA-seq and microarray studies.